Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Legislation providing more scrutiny for pharmacy benefit managers (PBMs) that failed to make it through Congress in the waning days of 2024 seems to still

Lif­era, the Sau­di Ara­bi­an-based con­tract man­u­fac­tur­er with back­ing from the na­tion’s Pub­lic In­vest­ment Fund, has part­nered with man­u­fac­tur­er Re­silience to es­tab­lish a pro­duc­tion site. Re­silience